01 1Erregierre SpA
02 1MSN Laboratories Private Limited
03 1Olon SpA
01 3Naftifine Hydrochloride
01 1India
02 2Italy
NDC Package Code : 49706-0915
Start Marketing Date : 2010-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0001
Start Marketing Date : 2014-05-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0531
Start Marketing Date : 2017-03-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A NAFTIFINE HCL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NAFTIFINE HCL, including repackagers and relabelers. The FDA regulates NAFTIFINE HCL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NAFTIFINE HCL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NAFTIFINE HCL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NAFTIFINE HCL supplier is an individual or a company that provides NAFTIFINE HCL active pharmaceutical ingredient (API) or NAFTIFINE HCL finished formulations upon request. The NAFTIFINE HCL suppliers may include NAFTIFINE HCL API manufacturers, exporters, distributors and traders.
click here to find a list of NAFTIFINE HCL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NAFTIFINE HCL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NAFTIFINE HCL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NAFTIFINE HCL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NAFTIFINE HCL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NAFTIFINE HCL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NAFTIFINE HCL suppliers with NDC on PharmaCompass.
We have 3 companies offering NAFTIFINE HCL
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
